http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2589283-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e8a82e18aa7eff278333cab3e11f943 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2014-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34f32a2c54fff5b30cdb2a297c013bcf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7c2abbbfda8fb1afa8442911944debb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8992f0d4d667d395d21dd9c935df3054 |
publicationDate | 2016-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2589283-C2 |
titleOfInvention | Method for prediction of antiviral therapy in chronic hepatitis c in adults and children |
abstract | FIELD: medicine. n SUBSTANCE: invention relates to hepatology and aims at predicting antiviral treatment response in chronic hepatitis C in adults and children. Before beginning the treatment, level of interferon in plasmacyitoid dendritic blood cells is defined and upon its value of 136.7 pg/mL and more predict the efficiency of antiviral therapy. n EFFECT: method provides more accurate prediction of effectiveness of therapy for selecting the optimum therapeutic approach in each patient. n 1 cl |
priorityDate | 2014-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 199.